Bausch Health Companies Inc. (BHC)
Market Cap | 3.01B |
Revenue (ttm) | 8.35B |
Net Income (ttm) | -186.00M |
Shares Out | 364.33M |
EPS (ttm) | -0.51 |
PE Ratio | n/a |
Forward PE | 2.37 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,436,891 |
Open | 8.19 |
Previous Close | 8.22 |
Day's Range | 8.14 - 8.35 |
52-Week Range | 5.57 - 10.23 |
Beta | 0.97 |
Analysts | Buy |
Price Target | 12.00 (+45.46%) |
Earnings Date | Nov 2, 2023 |
About BHC
Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, a... [Read more]
Full Company ProfileFinancial Performance
In 2022, BHC's revenue was $8.12 billion, a decrease of -3.68% compared to the previous year's $8.43 billion. Losses were -$225.00 million, -76.27% less than in 2021.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for BHC stock is "Buy." The 12-month stock price forecast is $12.0, which is an increase of 45.46% from the latest price.
News

Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United States
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NYSE: BHC)
NEW YORK , Sept. 26, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Bausch Health Companies Inc..

BHC DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action – BHC
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bausch Health Companies Inc. (NYSE: BHC) between August 6, 2020 and May 3, 2023, ...

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bausch Health Companies Inc....

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bausch Health Companies Inc....

BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit
LOS ANGELES , Sept. 22, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit aga...

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bausch Health Companies Inc. (BHC)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 25, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of inve...

BHC DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
NEW YORK , Sept. 21, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bausch Health Companies Inc. (NYSE: BHC) between August 6, 2020 an...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC
NEW YORK , Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC).

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bausch Health Companies Inc....

League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease
Partnership Aims to Educate Hispanic Communities About the Signs, Symptoms, and Prevalence of Gum Disease Collaboration Launches During Hispanic Heritage Month With Activations Featuring Patient Ambas...

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Bausch Health Companies Inc.(BHC) Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , Sept. 21, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC) of a class action securities lawsuit.

Bausch + Lomb's ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE...

Bausch Health shares fall after CFO resignation
Bausch Health Cos. Inc. BHC, -1.76% shares fell nearly 3% premarket on Tuesday after the company announced late Monday that chief financial officer Tom Vadaketh has resigned effective Oct. 13 to pursu...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NYSE: BHC)
NEW YORK , Sept. 19, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Bausch Health Companies Inc..

Bausch Health CFO Tom Vadaketh to resign effective Oct. 13
Bausch Health finance chief Tom Vadaketh will resign effective Oct. 13 to pursue another opportunity, the Canadian pharmaceutical company said in a regulatory filing Monday.

Bausch Health Announces CFO Transition Plan
LAVAL, QC / ACCESSWIRE / September 18, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) ("BHC" or the "Company") today announced that Tom Vadaketh, Executive Vice President, Chief Financial Officer,...

SEPTEMBER 25 DEADLINE: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bausch Health Companies Inc....

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Bausch Investors of a Lead Plaintiff Deadline of September 25, 2023
NEW YORK , Sept. 18, 2023 /PRNewswire/ -- Attention Bausch Health Companies Inc. ("Bausch") (NYSE: BHC) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced...

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bausch Health Companies Inc....

Bausch + Lomb Announces Pricing of Senior Secured Notes Offering
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Bausch + ...

Final Deadline Approaching for Bausch Health Companies Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. (BHC) Investors of September 25, 2023 Lead Plaintiff Deadline
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Bausch He...

New Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults
LAVAL, QE / ACCESSWIRE / September 12, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce that following its approval by Health Canada the new treatment PrUCERIS® (budesoni...

Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. comme...

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bausch Health Companies Inc....